0

Next generation sequencing market is expected to reach $35,503.66 million by 2030

 
2022
Next generation sequencing market is expected to reach $35,503.66 million by 2030

Report Code : A01718

quote The rise in technological advancements, especially nanopore sequencing in NGS and rise in the need to improve diagnostic procedures and ensure quality treatment is propelling the development is propelling the development of next generation sequencing market. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, “Next Generation Sequencing Market by Product Type, Application, Technology, End user, and: Opportunity Analysis and Industry Forecast, 2020-2030,” The global next generation sequencing market size was valued at $6,598.62 million in 2020, and is projected to reach $35,503.66 million by 2030, registering a CAGR of 18.2% from 2021 to 2030.

Next generation sequencing (NGS, NextGenSeq) is used for sequencing genomes at high speed and at low cost. It is also known as second generation sequencing (SGS) or massively parallel sequencing (MPS). The technology is used to determine the order of nucleotides in entire genomes or targeted regions of DNA or RNA This technology is used for the identification of biomarkers for early diagnosis as well as personalized treatments, which has significantly impacted the change of the traditional medicine model of diagnosis to a precision medicine model.

The impact of COVID-19 pandemic is expected to remain positive for the next generation sequencing industry. As Next-generation sequencing (NGS) diagnostic technology has the potential advantage of determining the genetic sequence of a virus and helping scientists understand the mutation of the virus. Furthermore, genome sequencing has been used to understand the spread of Covid-19 and has the potential to understand the impact of interventions and help guide treatments in the future. For instance, Covid-19 Genomics U.K. Consortium (COG-U.K.) was formed in March 2020 to analyze the coronavirus genome using Whole-Genome Sequencing (WGS. To fight against COVID -19 pandemic researchers and scientists together way to identify the new strain of corona virus without any prior knowledge organisms.

 A huge number of researches were conducted on DNA and RNA of corona virus to understand how it enters human cells and to learn about its pathogenesis. 

For instance, in June 2020, U.S. Food and Drug Administration announced the emergency use authorization (EUA) to Illumina, Inc., for first COVID-19 diagnostic test by using next generation sequence technology to identify the COVID-19 variants with rapid turnaround time. Subsequently, this leads to increase in demand for next generation sequencing technology in any biotechnology & pharma companies, universities, and laboratories.

Rise in technological advancements, especially nanopore sequencing in NGS, rise in the number of collaborations & partnerships to promote the use of NGS in hospitals & research centers, and increase in genome mapping programs throughout the world. For instance, in June 2021, Labcorp, a global leading life science company, and OmniSeq, a molecular diagnostic of Rosewell Park Comprehensive Cancer Center, together announced the launch of OmniSeq INSIGHT which is a next generation sequencing platform in order to advance the precision oncology and improve patient outcome. Moreover, in 2020, Quest Diagnostic, the world largest database of clinical lab results, launched automated next generation sequencing engine to provide accurate genetic testing for inherited disease. In addition, increase in investment in R&D activities increases the demand for NGS; thereby, providing lucrative opportunities for the market growth. However, accuracy & standardization concerns and ethical & legal limitations associated with NGS restrain the market growth.

By product type segment, the consumable segment held the largest share in 2020 and is anticipated to maintain its dominance during the forecast period. This large share is attributed to the fact that they are widely used throughout the sample preparation process and other pre-requisite steps of NGS. The service segment is estimated to grow at the highest CAGR 19.3% during the forecast period. Owing to technological advancements in sequencing platforms, surge in applications of next generation sequencing, and increase in genome mapping programs is going to boost the global next generation sequencing market in future.

North America accounted for the largest share in 2020, and is anticipated to maintain its dominance from 2020 to 2030, due to high expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR during the forecast period, as Governments of Asian countries are investing in the development of healthcare infrastructure

The next generation sequencing market is segmented on the basis of product type, application, technology, end user and region. By product, the market is classified into consumables, platforms, and services.

The consumables product segment is further classified based on sample preparation consumables and other consumables. The sample preparation consumables are further segmented into DNA fragmentation, end repair, A-Tailing & size selection, library preparation & target enrichment, and quality control. The platform NGS product segment is segmented into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II & Sequel System, and other sequencing platforms. The services segment is divided into sequencing services and data management. By application, this market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, agriculture & animal research, and other applications. By technology, the next generation sequencing technology market is classified into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, and other technologies. On the basis of end user, the market is classified into academic & research centers, pharmaceutical and biotechnology companies, hospital & clinics and other end user. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The report provides some of the key players operating in the next generation sequencing market include Illumine, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., Beijing Genomics Institute, Qiagen N.V., 454 Life Sciences Corporation (Roche Holding AG), Agilent Technologies, Inc. PerkinElmer, Inc., Genomatix GmbH, and PierianDx. and among others.

Key Findings Of The Study

  • North America occupied dominant position in global next generation sequencing market in 2020.
  • Asia-Pacific is estimated to grow at the highest CAGR 19.0% during the forecast period.
  • By application, Biomarker and cancer segment was the highest contributor to the next generation sequencing market, in 2020, and is projected to grow at a CAGR of 17.5% from 2021 to 2030. 
  • By product type, consumable segment was the highest contributor to the market, in 2020, and is estimated to grow at a CAGR of 17.7% during the forecast period. 
  • By technology, the sequencing by synthesis segment was the highest contributor to the market in 2020.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Next Generation Sequencing Market by Product (Consumables, Platforms, Services and Nerve Blockers), Application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Agriculture and Animal Research, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, and Other Technologies), and End User (Academic and Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Other End Users): Global Opportunity Analysis and Industry Forecast, 2021––2030 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Mar 2024

Hairbrush Market

Download Sample
rep-img

Published Date Mar 2024

Debt Security Market

Download Sample
rep-img

Published Date Mar 2024

Wood Adhesives Market

Download Sample

Buy Full Version
"Next generation sequencing market is expected to reach $35,503.66 million by 2030"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers